-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Market Perform on Allogene Therapeutics, Raises Price Target to $3.85

Benzinga·04/14/2026 15:42:49
Listen to the news
Bernstein analyst William Pickering maintains Allogene Therapeutics (NASDAQ:ALLO) with a Market Perform and raises the price target from $1.6 to $3.85.